A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
Condition(s):NeutropeniaLast Updated:August 27, 2010Completed
Hide Studies Not Open or Pending
Condition(s):NeutropeniaLast Updated:August 27, 2010Completed
Condition(s):Malignant Hemopathy; Duration of Neutropenia Following Chemotherapy > 10 DaysLast Updated:September 21, 2006Terminated
Condition(s):Chronic Atrophic Gastritis (CAG)Last Updated:July 9, 2013Completed
Condition(s):Cryptococcal Meningitis; HIV InfectionsLast Updated:November 4, 2021Completed
Condition(s):Systemic Aspergillosis; Systemic CandidiasisLast Updated:December 29, 2009Completed
Condition(s):Primary Visceral LeishmaniasisLast Updated:February 29, 2024Recruiting
Condition(s):Labour Analgesia and Neonate ActivityLast Updated:February 14, 2012Completed
Condition(s):GlioblastomaLast Updated:February 12, 2024Recruiting
Condition(s):BurnsLast Updated:September 29, 2022Terminated
Condition(s):Diabetic RetinopathyLast Updated:December 4, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.